Downloads: 1
| # | NCT02750826 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT01674140 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2 | NCT02927249 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 3 | NCT02465060 | Advanced Malignant Solid Neoplasm | Bladder Carcinoma | Breast Carcinoma | Cervical Carcinoma | Colon Carcinoma | Colorectal Carcinoma | Endometrial Carcinoma | Esophageal Carcinoma | Gastric Carcinoma | Glioma | Head and Neck Carcinoma | Kidney Carcinoma | Liver and Intrahepatic Bile Duct Carcinoma | Lung Carcinoma | Lymphoma | Malignant Uterine Neoplasm | Melanoma | Ovarian Carcinoma | Pancreatic Carcinoma | Plasma Cell Myeloma | Prostate Carcinoma | Rectal Carcinoma | Recurrent Bladder Carcinoma | Recurrent Breast Carcinoma | Recurrent Cervical Carcinoma | Recurrent Colon Carcinoma | Recurrent Colorectal Carcinoma | Recurrent Esophageal Carcinoma | Recurrent Gastric Carcinoma | Recurrent Glioma | Recurrent Head and Neck Carcinoma | Recurrent Liver Carcinoma | Recurrent Lung Carcinoma | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm | Recurrent Melanoma | Recurrent Ovarian Carcinoma | Recurrent Pancreatic Carcinoma | Recurrent Plasma Cell Myeloma | Recurrent Prostate Carcinoma | Recurrent Rectal Carcinoma | Recurrent Skin Carcinoma | Recurrent Thyroid Gland Carcinoma | Recurrent Uterine Corpus Carcinoma | Refractory Lymphoma | Refractory Malignant Solid Neoplasm | Refractory Plasma Cell Myeloma | Skin Carcinoma | Thyroid Gland Carcinoma | Uterine Corpus Cancer | |||||||||||||||||||||||||||||||||||
| 4 | NCT02488967 | Breast Adenocarcinoma | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Stage IB Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage IIIA Breast Cancer | Stage IIIC Breast Cancer | Triple-Negative Breast Carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 5 | NCT03373760 | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 6 | NCT01901094 | Stage II Breast Cancer | Stage IIIA Breast Cancer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 7 | NCT02193282 | ALK Gene Rearrangement | EGFR Exon 19 Deletion Mutation | EGFR NP_005219.2:p.L858R | Stage IB Non-Small Cell Lung Carcinoma AJCC v7 | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 8 | NCT02834013 | Acinar Cell Carcinoma | Adenoid Cystic Carcinoma | Adrenal Cortex Carcinoma | Adrenal Gland Pheochromocytoma | Anal Canal Neuroendocrine Carcinoma | Anal Canal Undifferentiated Carcinoma | Appendix Mucinous Adenocarcinoma | Bartholin Gland Transitional Cell Carcinoma | Bladder Adenocarcinoma | Cervical Adenocarcinoma | Cholangiocarcinoma | Chordoma | Colorectal Squamous Cell Carcinoma | Desmoid-Type Fibromatosis | Endometrial Transitional Cell Carcinoma | Endometrioid Adenocarcinoma | Esophageal Neuroendocrine Carcinoma | Esophageal Undifferentiated Carcinoma | Extrahepatic Bile Duct Carcinoma | Fallopian Tube Adenocarcinoma | Fallopian Tube Transitional Cell Carcinoma | Fibromyxoid Tumor | Gastric Neuroendocrine Carcinoma | Gastric Squamous Cell Carcinoma | Gastrointestinal Stromal Tumor | Giant Cell Carcinoma | Intestinal Neuroendocrine Carcinoma | Intrahepatic Cholangiocarcinoma | Lung Carcinoid Tumor | Lung Sarcomatoid Carcinoma | Major Salivary Gland Carcinoma | Malignant Odontogenic Neoplasm | Malignant Peripheral Nerve Sheath Tumor | Malignant Testicular Sex Cord-Stromal Tumor | Metaplastic Breast Carcinoma | Metastatic Malignant Neoplasm of Unknown Primary Origin | Minimally Invasive Lung Adenocarcinoma | Mixed Mesodermal (Mullerian) Tumor | Mucinous Adenocarcinoma | Mucinous Cystadenocarcinoma | Nasal Cavity Adenocarcinoma | Nasal Cavity Carcinoma | Nasopharyngeal Carcinoma | Nasopharyngeal Papillary Adenocarcinoma | Nasopharyngeal Undifferentiated Carcinoma | Oral Cavity Carcinoma | Oropharyngeal Undifferentiated Carcinoma | Ovarian Adenocarcinoma | Ovarian Germ Cell Tumor | Ovarian Mucinous Adenocarcinoma | Ovarian Squamous Cell Carcinoma | Ovarian Transitional Cell Carcinoma | Pancreatic Acinar Cell Carcinoma | Pancreatic Neuroendocrine Carcinoma | Paraganglioma | Paranasal Sinus Adenocarcinoma | Paranasal Sinus Carcinoma | Parathyroid Gland Carcinoma | Pituitary Gland Carcinoma | Placental Choriocarcinoma | Placental-Site Gestational Trophoblastic Tumor | Primary Peritoneal High Grade Serous Adenocarcinoma | Pseudomyxoma Peritonei | Rare Disorder | Scrotal Squamous Cell Carcinoma | Seminal Vesicle Adenocarcinoma | Seminoma | Serous Cystadenocarcinoma | Small Intestinal Adenocarcinoma | Small Intestinal Squamous Cell Carcinoma | Spindle Cell Neoplasm | Squamous Cell Carcinoma of the Penis | Teratoma With Malignant Transformation | Testicular Non-Seminomatous Germ Cell Tumor | Thyroid Gland Carcinoma | Tracheal Carcinoma | Transitional Cell Carcinoma | Undifferentiated Gastric Carcinoma | Ureter Adenocarcinoma | Ureter Squamous Cell Carcinoma | Urethral Adenocarcinoma | Urethral Squamous Cell Carcinoma | Vaginal Adenocarcinoma | Vaginal Squamous Cell Carcinoma, Not Otherwise Specified | Vulvar Carcinoma |
| 9 | NCT01515787 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 10 | NCT02445391 | Estrogen Receptor Negative | HER2/Neu Negative | Invasive Breast Carcinoma | Progesterone Receptor Negative | Stage II Breast Cancer | Stage IIA Breast Cancer | Stage IIB Breast Cancer | Stage III Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | Triple-Negative Breast Carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 11 | NCT01863550 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 12 | NCT02595905 | Breast Carcinoma Metastatic in the Brain | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Recurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | Triple-Negative Breast Carcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 13 | NCT02595944 | Stage IB Non-Small Cell Lung Carcinoma AJCC v7 | Stage II Non-Small Cell Lung Cancer AJCC v7 | Stage IIA Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIB Non-Small Cell Lung Carcinoma AJCC v7 | Stage IIIA Non-Small Cell Lung Cancer AJCC v7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 14 | NCT01953588 | Estrogen Receptor-positive Breast Cancer | HER2-negative Breast Cancer | Invasive Ductal Breast Carcinoma | Invasive Lobular Breast Carcinoma | Recurrent Breast Cancer | Stage II Breast Cancer | Stage IIIA Breast Cancer | Stage IIIB Breast Cancer | Stage IIIC Breast Cancer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 15 | NCT02154490 | Recurrent Squamous Cell Lung Carcinoma | Stage IV Squamous Cell Lung Carcinoma AJCC v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 16 | NCT00632853 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 17 | NCT03365882 | Colon Adenocarcinoma | ERBB2 Gene Amplification | Rectal Adenocarcinoma | Recurrent Colon Carcinoma | Recurrent Rectal Carcinoma | Stage III Colon Cancer AJCC v7 | Stage III Rectal Cancer AJCC v7 | Stage IIIA Colon Cancer AJCC v7 | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIB Rectal Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | Stage IIIC Rectal Cancer AJCC v7 | Stage IV Colon Cancer AJCC v7 | Stage IV Rectal Cancer AJCC v7 | Stage IVA Colon Cancer AJCC v7 | Stage IVA Rectal Cancer AJCC v7 | Stage IVB Colon Cancer AJCC v7 | Stage IVB Rectal Cancer AJCC v7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 18 | NCT02196181 | BRAF V600E Mutation Present | BRAF V600K Mutation Present | Recurrent Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 19 | NCT03244384 | Stage II Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage III Bladder Urothelial Carcinoma AJCC v6 and v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 20 | NCT02500797 | Dedifferentiated Liposarcoma | Gastrointestinal Stromal Tumor | Metastatic Liposarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Pleomorphic Liposarcoma | Stage III Bone Sarcoma AJCC v7 | Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Bone Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Stage IVA Bone Sarcoma AJCC v7 | Stage IVB Bone Sarcoma AJCC v7 | Unresectable Liposarcoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 21 | NCT02115282 | Estrogen Receptor Positive | HER2/Neu Negative | Male Breast Carcinoma | Progesterone Receptor Positive | Recurrent Breast Carcinoma | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Stage IV Breast Cancer AJCC v6 and v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 22 | NCT02224781 | BRAF NP_004324.2:p.V600X | Metastatic Melanoma | Recurrent Melanoma | Stage III Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 23 | NCT01872975 | Stage IB Breast Cancer | Stage II Breast Cancer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 24 | NCT03382561 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 25 | NCT03033576 | Stage III Cutaneous Melanoma AJCC v7 | Stage IIIA Cutaneous Melanoma AJCC v7 | Stage IIIB Cutaneous Melanoma AJCC v7 | Stage IIIC Cutaneous Melanoma AJCC v7 | Stage IV Cutaneous Melanoma AJCC v6 and v7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 26 | NCT02761057 | Stage III Renal Cell Cancer AJCC v7 | Stage IV Renal Cell Cancer AJCC v7 | Type 1 Papillary Renal Cell Carcinoma | Type 2 Papillary Renal Cell Carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 27 | NCT02595424 | Gastric Neuroendocrine Carcinoma | Intestinal Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Carcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 28 | NCT03468985 | c-MET Gene Amplification | MET Exon 14 Mutation | Metastatic Non-Squamous Non-Small Cell Lung Carcinoma | Recurrent Non-Squamous Non-Small Cell Lung Carcinoma | RET/PTC Rearrangement | ROS1 Gene Rearrangement | Stage IV Non-Small Cell Lung Cancer AJCC v7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 29 | NCT03092674 | Acute Myeloid Leukemia | Adult Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts-2 | Untreated Adult Acute Myeloid Leukemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 30 | NCT02912559 | Colon Adenocarcinoma | DNA Repair Disorder | Lynch Syndrome | Stage III Colon Cancer AJCC v7 | Stage IIIA Colon Cancer AJCC v7 | Stage IIIB Colon Cancer AJCC v7 | Stage IIIC Colon Cancer AJCC v7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 31 | NCT02601209 | High Grade Sarcoma | Metastatic Leiomyosarcoma | Metastatic Malignant Peripheral Nerve Sheath Tumor | Metastatic Synovial Sarcoma | Metastatic Undifferentiated Pleomorphic Sarcoma | Myxofibrosarcoma | Recurrent Leiomyosarcoma | Recurrent Malignant Peripheral Nerve Sheath Tumor | Recurrent Synovial Sarcoma | Recurrent Undifferentiated Pleomorphic Sarcoma | Uterine Corpus Leiomyosarcoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 32 | NCT03067181 | Adult Germ Cell Tumor | Childhood Extracranial Germ Cell Tumor | Childhood Germ Cell Tumor | Extragonadal Embryonal Carcinoma | Grade 2 Immature Ovarian Teratoma | Grade 3 Immature Ovarian Teratoma | Malignant Germ Cell Tumor | Stage I Ovarian Choriocarcinoma | Stage I Ovarian Embryonal Carcinoma | Stage I Ovarian Teratoma | Stage I Ovarian Yolk Sac Tumor | Stage I Testicular Choriocarcinoma AJCC v6 and v7 | Stage I Testicular Embryonal Carcinoma AJCC v6 and v7 | Stage I Testicular Yolk Sac Tumor AJCC v6 and v7 | Stage II Ovarian Choriocarcinoma | Stage II Ovarian Embryonal Carcinoma | Stage II Ovarian Yolk Sac Tumor | Stage II Testicular Choriocarcinoma AJCC v6 and v7 | Stage II Testicular Embryonal Carcinoma AJCC v6 and v7 | Stage II Testicular Yolk Sac Tumor AJCC v6 and v7 | Stage III Ovarian Choriocarcinoma | Stage III Ovarian Embryonal Carcinoma | Stage III Ovarian Yolk Sac Tumor | Stage III Testicular Choriocarcinoma AJCC v6 and v7 | Stage III Testicular Embryonal Carcinoma AJCC v6 and v7 | Stage III Testicular Yolk Sac Tumor AJCC v6 and v7 | Stage IV Ovarian Choriocarcinoma | Stage IV Ovarian Embryonal Carcinoma | Stage IV Ovarian Yolk Sac Tumor | Testicular Mixed Choriocarcinoma and Embryonal Carcinoma | Testicular Mixed Choriocarcinoma and Teratoma | Testicular Mixed Choriocarcinoma and Yolk Sac Tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 33 | NCT02734537 | Head and Neck Squamous Cell Carcinoma | Hypopharyngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma | Laryngeal Squamous Cell Carcinoma, Spindle Cell Variant | Lip and Oral Cavity Squamous Cell Carcinoma | p16INK4a Negative Oropharyngeal Squamous Cell Carcinoma | Stage III Hypopharyngeal Carcinoma AJCC v8 | Stage III Laryngeal Cancer AJCC v8 | Stage III Lip and Oral Cavity Cancer AJCC v8 | Stage III Oral Cavity Verrucous Carcinoma | Stage III Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | Stage IVA Hypopharyngeal Carcinoma AJCC v8 | Stage IVA Laryngeal Cancer AJCC v8 | Stage IVA Lip and Oral Cavity Cancer AJCC v8 | Stage IVA Oral Cavity Verrucous Carcinoma | Stage IVA Oropharyngeal (p16-Negative) Carcinoma AJCC v8 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 34 | NCT02954874 | Estrogen Receptor Negative | HER2/Neu Negative | Invasive Breast Carcinoma | Progesterone Receptor Negative | Stage 0 Breast Cancer AJCC v6 and v7 | Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Triple-Negative Breast Carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 35 | NCT02839707 | Fallopian Tube Clear Cell Adenocarcinoma | Fallopian Tube Endometrioid Adenocarcinoma | High Grade Fallopian Tube Serous Adenocarcinoma | High Grade Ovarian Serous Adenocarcinoma | Ovarian Clear Cell Adenocarcinoma | Ovarian Endometrioid Adenocarcinoma | Ovarian Seromucinous Carcinoma | Primary Peritoneal High Grade Serous Adenocarcinoma | Recurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal Carcinoma | Undifferentiated Fallopian Tube Carcinoma | Undifferentiated Ovarian Carcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 36 | NCT02032823 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 37 | NCT03419234 | Castration Levels of Testosterone | Castration-Resistant Prostate Carcinoma | Metastatic Prostate Carcinoma in the Soft Tissue | Prostate Carcinoma Metastatic in the Bone | Stage IV Prostate Adenocarcinoma AJCC v7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 38 | NCT01368588 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 39 | NCT02893930 | Pancreatic Neuroendocrine Tumor G1 | Pancreatic Neuroendocrine Tumor G2 | Refractory Pancreatic Neuroendocrine Carcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 40 | NCT01101451 | Cervical Adenocarcinoma | Cervical Adenosquamous Carcinoma | Cervical Squamous Cell Carcinoma, Not Otherwise Specified | Stage IA Cervical Cancer | Stage IB Cervical Cancer | Stage IIA Cervical Cancer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 41 | NCT02003222 | Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | BCR/ABL1 Fusion Protein Negative | Untreated Adult Acute Lymphoblastic Leukemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 42 | NCT02180867 | Adult Fibrosarcoma | Alveolar Soft Part Sarcoma | Angiomatoid Fibrous Histiocytoma | Atypical Fibroxanthoma | Clear Cell Sarcoma of Soft Tissue | Epithelioid Malignant Peripheral Nerve Sheath Tumor | Epithelioid Sarcoma | Extraskeletal Myxoid Chondrosarcoma | Extraskeletal Osteosarcoma | Fibrohistiocytic Neoplasm | Glomus Tumor of the Skin | Inflammatory Myofibroblastic Tumor | Intimal Sarcoma | Leiomyosarcoma | Liposarcoma | Low Grade Fibromyxoid Sarcoma | Low Grade Myofibroblastic Sarcoma | Malignant Cutaneous Granular Cell Tumor | Malignant Peripheral Nerve Sheath Tumor | Malignant Triton Tumor | Mesenchymal Chondrosarcoma | Myxofibrosarcoma | Myxoid Chondrosarcoma | Myxoinflammatory Fibroblastic Sarcoma | Nerve Sheath Neoplasm | PEComa | Pericytic Neoplasm | Plexiform Fibrohistiocytic Tumor | Sclerosing Epithelioid Fibrosarcoma | Stage IB Soft Tissue Sarcoma AJCC v7 | Stage IIB Soft Tissue Sarcoma AJCC v7 | Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Synovial Sarcoma | Undifferentiated (Embryonal) Sarcoma | Undifferentiated High Grade Pleomorphic Sarcoma of Bone | |||||||||||||||||||||||||||||||||||||||||||||||||
| 43 | NCT02516423 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 44 | NCT02567435 | Alveolar Rhabdomyosarcoma | Botryoid-Type Embryonal Rhabdomyosarcoma | Embryonal Rhabdomyosarcoma | Rhabdomyosarcoma | Sclerosing Rhabdomyosarcoma | Spindle Cell Rhabdomyosarcoma | Untreated Childhood Rhabdomyosarcoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 45 | NCT03269669 | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Grade 3a Follicular Lymphoma | Recurrent Follicular Lymphoma | Refractory Follicular Lymphoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 46 | NCT02306161 | Metastatic Ewing Sarcoma | Metastatic Malignant Neoplasm in the Bone | Metastatic Malignant Neoplasm in the Bone Marrow | Metastatic Malignant Neoplasm in the Lung | Metastatic Peripheral Primitive Neuroectodermal Tumor of Bone | Peripheral Primitive Neuroectodermal Tumor of Soft Tissues | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 47 | NCT03191149 | EGFR Exon 20 Insertion Mutation | Recurrent Non-Small Cell Lung Carcinoma | Stage IIIB Non-Small Cell Lung Cancer AJCC v7 | Stage IV Non-Small Cell Lung Cancer AJCC v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 48 | NCT00492778 | Endometrial Adenocarcinoma | Endometrial Adenosquamous Carcinoma | Endometrial Clear Cell Adenocarcinoma | Endometrial Endometrioid Adenocarcinoma, Variant With Squamous Differentiation | Endometrial Serous Adenocarcinoma | Recurrent Uterine Corpus Carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 49 | NCT03233711 | Anal Basaloid Carcinoma | Anal Canal Cloacogenic Carcinoma | Anal Margin Squamous Cell Carcinoma | Stage II Anal Canal Cancer AJCC v6 and v7 | Stage IIB Anal Cancer AJCC v8 | Stage III Anal Canal Cancer AJCC v6 and v7 | Stage IIIA Anal Canal Cancer AJCC v6 and v7 | Stage IIIB Anal Canal Cancer AJCC v6 and v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 50 | NCT03070886 | Stage I Prostate Adenocarcinoma | Stage II Prostate Adenocarcinoma | Stage III Prostate Adenocarcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 51 | NCT02152137 | Anaplastic Thyroid Cancer | Recurrent Thyroid Cancer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 52 | NCT02997228 | Colorectal Adenocarcinoma | Mismatch Repair Deficiency | Stage IV Colorectal Cancer AJCC v7 | Stage IVA Colorectal Cancer AJCC v7 | Stage IVB Colorectal Cancer AJCC v7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 53 | NCT02883049 | B Acute Lymphoblastic Leukemia | Central Nervous System Leukemia | Ph-Like Acute Lymphoblastic Leukemia | Testicular Leukemia | Untreated Adult Acute Lymphoblastic Leukemia | Untreated Childhood Acute Lymphoblastic Leukemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 54 | NCT02176967 | Ganglioneuroblastoma | Localized Resectable Neuroblastoma | Localized Unresectable Neuroblastoma | Regional Neuroblastoma | Stage 4 Neuroblastoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 55 | NCT03267433 | CD20 Positive | Mantle Cell Lymphoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 56 | NCT01096368 | Childhood Infratentorial Ependymoma | Childhood Supratentorial Ependymoma | Newly Diagnosed Childhood Ependymoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 57 | NCT03055013 | Sarcomatoid Renal Cell Carcinoma | Stage II Renal Cell Cancer AJCC v7 | Stage III Renal Cell Cancer AJCC v7 | Unclassified Renal Cell Carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 58 | NCT02101853 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 59 | NCT02521493 | Blasts 5 Percent or More of Bone Marrow Nucleated Cells | Childhood Acute Myeloid Leukemia | Childhood Myelodysplastic Syndrome | Cytopenia | Down Syndrome | Myeloid Leukemia Associated With Down Syndrome | Myeloproliferative Neoplasm | Trisomy 21 | Trisomy 21 Mosaicism | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 60 | NCT02339740 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 61 | NCT02004275 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 62 | NCT02828358 | Acute Leukemia of Ambiguous Lineage | Childhood B Acute Lymphoblastic Leukemia | KMT2A Gene Rearrangement | Mixed Phenotype Acute Leukemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 63 | NCT02166463 | Ann Arbor Stage IIB Hodgkin Lymphoma | Ann Arbor Stage IIIB Hodgkin Lymphoma | Ann Arbor Stage IV Hodgkin Lymphoma | Ann Arbor Stage IVA Hodgkin Lymphoma | Ann Arbor Stage IVB Hodgkin Lymphoma | Childhood Hodgkin Lymphoma | Classic Hodgkin Lymphoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 64 | NCT00887146 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 65 | NCT02724579 | Medulloblastoma | Untreated Childhood Medulloblastoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 66 | NCT03137771 | Recurrent Non-Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 67 | NCT02443077 | Diffuse Large B-Cell Lymphoma Activated B-Cell Type | Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | High Grade B-Cell Lymphoma, Not Otherwise Specified | Recurrent Burkitt Lymphoma | Recurrent Diffuse Large B-Cell Lymphoma | Refractory Burkitt Lymphoma | Refractory Diffuse Large B-Cell Lymphoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 68 | NCT02179086 | Adult Giant Cell Glioblastoma | Adult Glioblastoma | Adult Gliosarcoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 69 | NCT02775851 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 70 | NCT01595061 | Stage IIIA Vulvar Cancer AJCC v7 | Stage IIIB Vulvar Cancer AJCC v7 | Stage IIIC Vulvar Cancer AJCC v7 | Stage IVA Vulvar Cancer AJCC v7 | Vulvar Squamous Cell Carcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 71 | NCT01979536 | Anaplastic Large Cell Lymphoma, ALK-Positive | Ann Arbor Stage II Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage III Noncutaneous Childhood Anaplastic Large Cell Lymphoma | Ann Arbor Stage IV Noncutaneous Childhood Anaplastic Large Cell Lymphoma | CD30-Positive Neoplastic Cells Present | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 72 | NCT02135042 | Epstein-Barr Virus Infection | Stage II Nasopharyngeal Carcinoma | Stage III Nasopharyngeal Carcinoma | Stage IVA Nasopharyngeal Carcinoma | Stage IVB Nasopharyngeal Carcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 73 | NCT03007147 | B Acute Lymphoblastic Leukemia | BCR-ABL1 Fusion Protein Expression | Minimal Residual Disease | Philadelphia Chromosome Positive | T Acute Lymphoblastic Leukemia | Untreated Adult Acute Lymphoblastic Leukemia | Untreated Childhood Acute Lymphoblastic Leukemia | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 74 | NCT01220583 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 75 | NCT02844816 | Recurrent Bladder Urothelial Carcinoma | Stage 0a Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage 0is Bladder Urothelial Carcinoma AJCC v6 and v7 | Stage I Bladder Cancer With Carcinoma In Situ | Stage I Bladder Urothelial Carcinoma AJCC v6 and v7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 76 | NCT00980954 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 77 | NCT02364557 | Dyspnea | Fatigue | Nausea and Vomiting | Pain | Stage IV Breast Cancer | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 78 | NCT03371719 | PSA Progression | Stage III Prostate Adenocarcinoma | Stage IV Prostate Adenocarcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 79 | NCT03367702 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 80 | NCT03228537 | Biphasic Mesothelioma | Epithelioid Mesothelioma | Stage I Pleural Malignant Mesothelioma AJCC v7 | Stage IA Pleural Malignant Mesothelioma AJCC v7 | Stage IB Pleural Malignant Mesothelioma AJCC v7 | Stage II Pleural Malignant Mesothelioma AJCC v7 | Stage III Pleural Malignant Mesothelioma AJCC v7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 81 | NCT03091660 | Stage 0 Bladder Urothelial Carcinoma | Stage 0is Bladder Urothelial Carcinoma | Stage I Bladder Urothelial Carcinoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 82 | NCT03150693 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 83 | NCT02143414 | Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | Philadelphia Chromosome Positive | Recurrent Adult Acute Lymphoblastic Leukemia | Refractory Adult Acute Lymphoblastic Leukemia | Untreated Adult Acute Lymphoblastic Leukemia | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 84 | NCT03304639 | Stage III Merkel Cell Carcinoma AJCC v7 | Stage IIIA Merkel Cell Carcinoma AJCC v7 | Stage IIIB Merkel Cell Carcinoma AJCC v7 | Stage IV Merkel Cell Carcinoma AJCC v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 85 | NCT01042522 | Ovarian Granulosa Cell Tumor | Ovarian Gynandroblastoma | Ovarian Sertoli-Leydig Cell Tumor | Ovarian Sex Cord Tumor With Annular Tubules | Ovarian Sex Cord-Stromal Tumor | Ovarian Sex Cord-Stromal Tumor of Mixed or Unclassified Cell Types | Ovarian Steroid Cell Tumor | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 86 | NCT03180268 | Grade II Meningioma | Intracranial Meningioma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 87 | NCT02867592 | Adrenal Cortex Carcinoma | Adult Alveolar Soft Part Sarcoma | Adult Clear Cell Sarcoma of Soft Parts | Adult Hepatocellular Carcinoma | Adult Rhabdomyosarcoma | Adult Soft Tissue Sarcoma | Childhood Alveolar Soft Part Sarcoma | Childhood Central Nervous System Neoplasm | Childhood Clear Cell Sarcoma of Soft Parts | Childhood Hepatocellular Carcinoma | Childhood Rhabdomyosarcoma | Childhood Soft Tissue Sarcoma | Childhood Solid Neoplasm | Ewing Sarcoma | Hepatoblastoma | Hepatocellular Carcinoma | Recurrent Adrenal Cortex Carcinoma | Recurrent Adult Hepatocellular Carcinoma | Recurrent Adult Soft Tissue Sarcoma | Recurrent Alveolar Soft Part Sarcoma | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Childhood Hepatocellular Carcinoma | Recurrent Childhood Soft Tissue Sarcoma | Recurrent Ewing Sarcoma | Recurrent Hepatoblastoma | Recurrent Malignant Solid Neoplasm | Recurrent Osteosarcoma | Recurrent Renal Cell Carcinoma | Recurrent Rhabdomyosarcoma | Refractory Osteosarcoma | Renal Cell Carcinoma | Thyroid Gland Medullary Carcinoma | Wilms Tumor | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| 88 | NCT01622868 | ERBB2 Gene Amplification | HER2 Positive Breast Carcinoma | Invasive Breast Carcinoma | Metastatic Malignant Neoplasm in the Brain | Recurrent Breast Carcinoma | Stage IV Breast Cancer AJCC v6 and v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 89 | NCT03233204 | Advanced Malignant Solid Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma | Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma | Deleterious ATM Gene Mutation | Deleterious BRCA1 Gene Mutation | Deleterious BRCA2 Gene Mutation | Deleterious RAD51C Gene Mutation | Deleterious RAD51D Gene Mutation | Histiocytosis | Low Grade Glioma | Malignant Glioma | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Childhood Ependymoma | Recurrent Childhood Malignant Germ Cell Tumor | Recurrent Childhood Non-Hodgkin Lymphoma | Recurrent Childhood Rhabdomyosarcoma | Recurrent Childhood Soft Tissue Sarcoma | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Recurrent Glioma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Solid Neoplasm | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Osteosarcoma | Refractory Central Nervous System Neoplasm | Refractory Langerhans Cell Histiocytosis | Refractory Malignant Solid Neoplasm | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Rhabdoid Tumor | Wilms Tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 90 | NCT03220035 | Advanced Malignant Solid Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma | Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma | BRAF NP_004324.2:p.V600X | Ependymoma | Ewing Sarcoma | Hepatoblastoma | Histiocytosis | Langerhans Cell Histiocytosis | Malignant Germ Cell Tumor | Malignant Glioma | Osteosarcoma | Peripheral Primitive Neuroectodermal Tumor | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Childhood Non-Hodgkin Lymphoma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Central Nervous System Neoplasm | Refractory Malignant Solid Neoplasm | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Rhabdoid Tumor | Rhabdomyosarcoma | Soft Tissue Sarcoma | Wilms Tumor | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 91 | NCT03210714 | Advanced Malignant Solid Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma | Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma | FGFR1 Gene Mutation | FGFR2 Gene Mutation | FGFR3 Gene Mutation | FGFR4 Gene Mutation | Histiocytosis | Low Grade Glioma | Malignant Glioma | Recurrent Central Nervous System Neoplasm | Recurrent Childhood Ependymoma | Recurrent Childhood Malignant Germ Cell Tumor | Recurrent Childhood Medulloblastoma | Recurrent Childhood Non-Hodgkin Lymphoma | Recurrent Childhood Rhabdomyosarcoma | Recurrent Childhood Soft Tissue Sarcoma | Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Recurrent Osteosarcoma | Refractory Central Nervous System Neoplasm | Refractory Langerhans Cell Histiocytosis | Refractory Malignant Solid Neoplasm | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Rhabdoid Tumor | Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Wilms Tumor | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| 92 | NCT03213652 | Advanced Malignant Solid Neoplasm | ALK Fusion Protein Expression | ALK Gene Mutation | ALK Gene Translocation | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma | Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma | Histiocytosis | Recurrent Childhood Central Nervous System Neoplasm | Recurrent Childhood Non-Hodgkin Lymphoma | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Refractory Central Nervous System Neoplasm | Refractory Malignant Solid Neoplasm | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | ROS1 Fusion Positive | ROS1 Gene Mutation | ROS1 Gene Translocation | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 93 | NCT02375204 | Germ Cell Tumor | Teratoma | Choriocarcinoma | Germinoma | Mixed Germ Cell Tumor | Yolk Sac Tumor | Childhood Teratoma | Malignant Germ Cell Neoplasm | Extragonadal Seminoma | Non-seminomatous Germ Cell Tumor | Seminoma | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 94 | NCT03213704 | Advanced Malignant Solid Neoplasm | Ann Arbor Stage III Childhood Non-Hodgkin Lymphoma | Ann Arbor Stage IV Childhood Non-Hodgkin Lymphoma | Malignant Glioma | NTRK1 Fusion Positive | NTRK2 Fusion Positive | NTRK3 Fusion Positive | Recurrent Central Nervous System Neoplasm | Recurrent Childhood Ependymoma | Recurrent Childhood Malignant Germ Cell Tumor | Recurrent Childhood Medulloblastoma | Recurrent Childhood Non-Hodgkin Lymphoma | Recurrent Childhood Rhabdomyosarcoma | Recurrent Childhood Soft Tissue Sarcoma | Recurrent Ewing Sarcoma | Recurrent Glioma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Solid Neoplasm | Recurrent Neuroblastoma | Recurrent Osteosarcoma | Recurrent Peripheral Primitive Neuroectodermal Tumor | Refractory Central Nervous System Neoplasm | Refractory Childhood Malignant Germ Cell Tumor | Refractory Langerhans Cell Histiocytosis | Refractory Malignant Solid Neoplasm | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Rhabdoid Tumor | Stage III Osteosarcoma AJCC v7 | Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Osteosarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Stage IVA Osteosarcoma AJCC v7 | Stage IVB Osteosarcoma AJCC v7 | Wilms Tumor | |||||||||||||||||||||||||||||||||||||||||||||||||
| 95 | NCT03224767 | BRAF V600E Mutation Present | Papillary Craniopharyngioma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 96 | NCT03375320 | Atypical Carcinoid Tumor | Carcinoid Tumor | Digestive System Neuroendocrine Neoplasm | Enterochromaffin Cell Serotonin-Producing Pancreatic Neuroendocrine Tumor | Functional Pancreatic Neuroendocrine Tumor | Intermediate Grade Lung Neuroendocrine Neoplasm | Low Grade Lung Neuroendocrine Neoplasm | Lung Atypical Carcinoid Tumor | Lung Carcinoid Tumor | Metastatic Digestive System Neuroendocrine Tumor G1 | Neuroendocrine Neoplasm | Nonfunctional Pancreatic Neuroendocrine Tumor | Pancreatic Neuroendocrine Tumor | Stage IIIA Digestive System Neuroendocrine Tumor AJCC v7 | Stage IIIB Digestive System Neuroendocrine Tumor AJCC v7 | Stage IV Digestive System Neuroendocrine Tumor AJCC v7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 97 | NCT03213678 | Advanced Malignant Solid Neoplasm | Ann Arbor Stage III Non-Hodgkin Lymphoma | Ann Arbor Stage IV Non-Hodgkin Lymphoma | Malignant Glioma | Recurrent Central Nervous System Neoplasm | Recurrent Childhood Ependymoma | Recurrent Ewing Sarcoma | Recurrent Glioma | Recurrent Hepatoblastoma | Recurrent Langerhans Cell Histiocytosis | Recurrent Malignant Germ Cell Tumor | Recurrent Malignant Solid Neoplasm | Recurrent Medulloblastoma | Recurrent Neuroblastoma | Recurrent Non-Hodgkin Lymphoma | Recurrent Osteosarcoma | Recurrent Peripheral Primitive Neuroectodermal Tumor | Recurrent Rhabdomyosarcoma | Recurrent Soft Tissue Sarcoma | Refractory Central Nervous System Neoplasm | Refractory Langerhans Cell Histiocytosis | Refractory Malignant Germ Cell Tumor | Refractory Malignant Solid Neoplasm | Refractory Neuroblastoma | Refractory Non-Hodgkin Lymphoma | Rhabdoid Tumor | Stage III Osteosarcoma AJCC v7 | Stage III Soft Tissue Sarcoma AJCC v7 | Stage IV Osteosarcoma AJCC v7 | Stage IV Soft Tissue Sarcoma AJCC v7 | Stage IVA Osteosarcoma AJCC v7 | Stage IVB Osteosarcoma AJCC v7 | TSC1 Gene Mutation | TSC2 Gene Mutation | Wilms Tumor | ||||||||||||||||||||||||||||||||||||||||||||||||||
| 98 | NCT03533582 | Childhood Hepatocellular Carcinoma | Childhood Malignant Liver Neoplasm | Elevated Alpha-Fetoprotein | Hepatoblastoma | SMARCB1 Gene Mutation | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 99 | NCT02513394 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 100 | NCT02849496 | BRCA1 Gene Mutation | BRCA2 Gene Mutation | Estrogen Receptor Negative | HER2/Neu Negative | Progesterone Receptor Negative | Recurrent Breast Carcinoma | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB Breast Cancer AJCC v7 | Stage IIIC Breast Cancer AJCC v7 | Stage IV Breast Cancer AJCC v6 and v7 | Triple-Negative Breast Carcinoma |